The enhancement of N-acetylcysteine on intestinal absorption and oral bioavailability of hydrophobic curcumin.
Bovine serum albumin nanoparticle
Curcumin
Gastrointestinal tract
N-acetylcysteine
Oral bioavailability
Journal
European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences
ISSN: 1879-0720
Titre abrégé: Eur J Pharm Sci
Pays: Netherlands
ID NLM: 9317982
Informations de publication
Date de publication:
01 Nov 2020
01 Nov 2020
Historique:
received:
07
05
2020
revised:
22
07
2020
accepted:
04
08
2020
pubmed:
9
8
2020
medline:
27
5
2021
entrez:
9
8
2020
Statut:
ppublish
Résumé
To solve the low oral bioavailability of curcumin (CUR) due to the limits imposed by gastrointestinal (GI) barrier, we constructed a nano delivery system to evaluate the effect of N-acetyl-L-cysteine (NAC) on intestinal absorption and oral bioavailability of CUR. CUR was first encapsulated in bovine serum albumin nanoparticles (CUR-BSA-NPs), and then was further modified by NAC (CUR-NBSA-NPs). In situ single-pass intestinal perfusion assay demonstrated that CUR-NBSA-NPs displayed excellent permeation and absorption rates in GI tract. Additionally, the distribution study in GI tract revealed that more NBSA-NPs were absorbed by intestinal segments compared to the BSA nanoparticles. Plasma concentration-time curves in rats showed that AUC
Identifiants
pubmed: 32763460
pii: S0928-0987(20)30295-5
doi: 10.1016/j.ejps.2020.105506
pii:
doi:
Substances chimiques
Drug Carriers
0
Curcumin
IT942ZTH98
Acetylcysteine
WYQ7N0BPYC
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
105506Informations de copyright
Copyright © 2020 Elsevier B.V. All rights reserved.